Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for CorMedix (CRMD) over the last 12 years, with Q3 2025 value amounting to 0.43.

  • CorMedix's Asset Utilization Ratio rose 13611.57% to 0.43 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.43, marking a year-over-year increase of 13611.57%. This contributed to the annual value of 0.0 for FY2022, which is 6907.28% down from last year.
  • Latest data reveals that CorMedix reported Asset Utilization Ratio of 0.43 as of Q3 2025, which was up 13611.57% from 0.6 recorded in Q2 2025.
  • CorMedix's 5-year Asset Utilization Ratio high stood at 0.62 for Q1 2025, and its period low was 0.0 during Q1 2024.
  • Over the past 5 years, CorMedix's median Asset Utilization Ratio value was 0.0 (recorded in 2021), while the average stood at 0.13.
  • Within the past 5 years, the most significant YoY rise in CorMedix's Asset Utilization Ratio was 68431641.02% (2024), while the steepest drop was 15832.66% (2024).
  • Quarter analysis of 5 years shows CorMedix's Asset Utilization Ratio stood at 0.0 in 2021, then plummeted by 60.16% to 0.0 in 2022, then crashed by 97.49% to 0.0 in 2023, then skyrocketed by 1674137.72% to 0.44 in 2024, then dropped by 3.48% to 0.43 in 2025.
  • Its Asset Utilization Ratio stands at 0.43 for Q3 2025, versus 0.6 for Q2 2025 and 0.62 for Q1 2025.